DOI:
10.1055/s-00034924
Nuklearmedizin - NuclearMedicine
LinksClose Window
References
Ahmadzadehfar H, Rahbar K, Kürpig S. et al.
Early side effects and first results of radioligand therapy with (177)Lu-DKFZ-617 PSMA of castrate-resistant metastatic prostate cancer: a two-centre study.
EJNMMI Res 2015;
5: 114
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.